News | Biopsy Systems | March 23, 2017

Karmanos Cancer Institute Now Offering Fusion Biopsy System for Prostate Cancer Detection

UroNav Fusion Biopsy System combines MRI with ultrasound in real time for better visualization of tumors

Karmanos Cancer Institute, UroNav Fusion Biopsy System, prostate cancer

March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroNav Fusion Biopsy System, which fuses three-dimensional magnetic resonance imaging (MRI) images of the prostate with live ultrasound images to precisely target prostate biopsies.

"An MRI is better at seeing tumors in the prostate," said Michael Cher, M.D., professor and chair of urology at Karmanos Cancer Institute and Wayne State University School of Medicine. "MRI images are highly detailed, and our radiologists are experts at finding tumors on the images.  Our urologists are also skilled at performing prostate biopsies using live ultrasound images. 

"With this new MRI-ultrasound image fusion system, our urologists are able to biopsy suspicious MRI-detected areas while doing live ultrasound."

Those who are eligible for this technology are men who have elevated prostate-specific antigen (PSA) test results and have never had a prostate biopsy, or men diagnosed with a small amount of cancer who are considering active surveillance. The system also is used to detect tumor progression in men who have been on active surveillance for several years. Cher said these are common scenarios in the Karmanos urology clinic. Demand for the system is increasing rapidly.

Patients typically have an MRI performed first, which takes about an hour. Radiologists then analyze the images and identify suspicious areas using a standardized scoring system. At the time of biopsy, which occurs after the MRI, urologists import the MRI images digitally into the UroNav system where they are fused with the live ultrasound images captured during the biopsy procedure.

Through the use of software, the UroNav machine takes the two images and fuses them together in a three-dimensional fashion. The images move and change in real time as the urologist performs the biopsy procedure.

"Previously, we used ultrasound alone for biopsies," Cher said. "The biopsies were distributed throughout the prostate in a systematic fashion. Now, with the fusion of the MRI and ultrasound images, we perform targeted biopsies of suspicious areas. We are better at finding cancers, and therefore better at determining the best treatment plan for each patient."

Cher mentioned that prostate cancer detection methods have evolved over the years, from digital rectal exams, which were a very poor method of detecting prostate cancer; to the PSA blood test; to ultrasound, which could see the prostate well but wasn't very good at seeing tumors within the prostate.

"This technology is huge for urology," said Cher. "We're going to more accurately determine if the patient has cancer and how much cancer the patient has. We can give more personalized treatments tailored towards the patient based on more accurate diagnosis and staging."

For more information: www.invivocorp.com

Related Content

Bringing the comfort of a personal movie theater into the magnetic resonance imaging (MRI) scanning procedure. Combining vivid video and symphonic-quality audio, Resonance Technology offers the ultimate in-patient comfort. CinemaVision is an immersive entertainment system with an MR Headset and Visor that helps to alleviate anxiety and claustrophobia by transporting patients to a breathtaking virtual world
News | Magnetic Resonance Imaging (MRI) | December 04, 2020
December 4, 2020 — Bringing the comfort of a personal movie theater into the...
Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography
News | Radiology Imaging | December 02, 2020
December 2, 2020 — Samsung Electronics Co., Ltd.
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Getty Images

News | Prostate Cancer | December 02, 2020
December 2, 2020 — ...
By eliminating the need to move neonates from the NICU to the radiology department, Aspect Imaging’s Embrace enables a safer way to perform the MRI procedure
News | Magnetic Resonance Imaging (MRI) | December 01, 2020
December 1, 2020 — Based on its recent analysis of the global neonatal intensive care unit magnetic resonance imaging
Resoundant Inc., announced hat it has entered into a strategic partnership with United Imaging Healthcare to begin offering advanced magnetic resonance elastography (MRE) on leading United Imaging MRI systems.
News | Magnetic Resonance Imaging (MRI) | November 30, 2020
November 30, 2020 — Resoundant Inc., announced that it has entered into a strategic partnership with...
Chest CT images in a 34-year-old man with fever for 4 days. Positive result of reverse-transcription polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 using a swab sample was obtained on February 8, 2020. Dates of examination are shown on images. A, Chest CT scan with magnification of lesions in coronal and sagittal planes shows a nodule with reversed halo sign in left lower lobe (box) at the early stage of the pneumonia. B, Chest CT scans in different axial planes and coro

Chest CT images in a 34-year-old man with fever for 4 days. Positive result of reverse-transcription polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 using a swab sample was obtained on February 8, 2020. Dates of examination are shown on images. A, Chest CT scan with magnification of lesions in coronal and sagittal planes shows a nodule with reversed halo sign in left lower lobe (box) at the early stage of the pneumonia. B, Chest CT scans in different axial planes and coronal reconstruction show bilateral multifocal ground-glass opacities. The nodular opacity resolved.

News | Coronavirus (COVID-19) | November 29, 2020
November 29, 2020 — The Radiological Society of North America (...